drugset / Trial / NCT04252963

Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)

NCT04252963

Phase 4 Unknown 346 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

A phase 4 study to evaluate efficacy and safety of MUCOLASE tablet (streptokinase • streptodornase)

Timeline

Start
2018-11-02
Primary completion
2021-02
Completion
2021-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Streptokinase Protein / enzyme biologic
Subject streptodornase Protein / enzyme biologic